{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-111298","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2025-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.935650+00:00","generated_at":"2026-05-16T19:07:29.240559+00:00","sec_items":["1.01","3.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Oramed adopts poison pill; declares dividend of one Right per share","bullets":["Rights trigger at 15% beneficial ownership; each Right allows purchase of one share at $10.00.","Dividend payable Nov 27, 2025 to holders of record Nov 27, 2025; Rights expire in 3 years.","Board may redeem Rights at $0.012 per Right prior to triggering event; distribution is not taxable.","Rights plan designed to protect against hostile takeovers and ensure fair treatment of shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-111298","json":"https://secwatch.observer/filing/0001213900-25-111298.json","markdown":"https://secwatch.observer/filing/0001213900-25-111298.md","text":"https://secwatch.observer/filing/0001213900-25-111298.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025111298/0001213900-25-111298-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025111298/ea0265959-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:07:29.240559+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}